Share

Aehr Test Systems (AEHR.NASDAQ) AI OPINIONS & ADVISOR ANALYSIS

Read and compare the 14 individual AI Advisor deep-dive reports, including their forecast paths, ratings, price targets, and reasoning.

Updated on 20 September 2026Deep analysis 20 September 2026

Publisher

Russlan Ramdowar

25 min readAudit All Past Forecasts

14 AI Advisor Reports

Select an advisor report.

SynthesizerCombines all advisor views

Synthesis of 14 independent opinions

Diversity of ModelsSame approach, varied models

Diversity of FrameworksDifferent investing styles

AI Researcher

Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Partial Sell

5-Year Return Est.

+31.1%

AEHR.NASDAQ does not currently pay dividends

1. Investment Thesis — Base Case

The central tension is not whether revenue triples — backlog, named orders and guidance make that probable — but whether gross margin and share count let the tripling reach the shareholder. Base case: fiscal 2027 lands near $140M, the first profitable year since 2024 arrives, and recovers into the low forties rather than back to 49%. Earnings growth is then real but slower than the multiple assumes, so the share price advances modestly while the valuation deflates toward the fundamentals. Investors earn business growth, not rerating, and endure violent quarterly swings to collect it.

Fiscal 2027 revenue of $130-150M against a $2.87B market capitalisation implies roughly 20x forward sales.
Sustaining today's price requires about $3.00 earnings per share by fiscal 2031 on a 30x multiple.
Cross-check: $400M revenue at 25% net margin across 33 million shares produces exactly that per-share outcome.

Historical prices and published forecast

Observed price
Published advisor forecast

Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.

View chart values

Historical prices and published forecast — published chart values
Series	Date	Value (USD)
Observed price	2021-09-17	11.15
Observed price	2021-10-07	16.52
Observed price	2021-10-11	19.30
Observed price	2021-10-31	22.4
Observed price	2021-11-04	25.3
Observed price	2021-11-24	17.46
Observed price	2021-11-28	17.25
Observed price	2021-12-06	14.89
Observed price	2021-12-30	23.8
Observed price	2022-01-11	14.80
Observed price	2022-01-15	13.04
Observed price	2022-01-27	11.05
Observed price	2022-02-16	14.45
Observed price	2022-02-20	12.24
Observed price	2022-03-04	12.55
Observed price	2022-03-16	10.05
Observed price	2022-03-28	10.94
Observed price	2022-04-13	9.04
Observed price	2022-05-03	8.35
Observed price	2022-05-11	7.07
Observed price	2022-05-23	7.85
Observed price	2022-06-04	9.32
Observed price	2022-06-08	8.96
Observed price	2022-06-20	7.67
Observed price	2022-07-06	7.31
Observed price	2022-07-22	11.79
Observed price	2022-07-26	10.94
Observed price	2022-08-11	17.89
Observed price	2022-08-19	17.43
Observed price	2022-09-04	13.29
Observed price	2022-09-12	14.09
Observed price	2022-09-16	15.55
Observed price	2022-10-06	13.87
Observed price	2022-10-26	21.7
Observed price	2022-11-03	19.00
Observed price	2022-11-15	25.6
Observed price	2022-11-23	26.4
Observed price	2022-12-13	23.3
Observed price	2022-12-17	23.2
Observed price	2023-01-02	18.84
Observed price	2023-01-10	27.4
Observed price	2023-01-26	36.5
Observed price	2023-02-07	36.5
Observed price	2023-02-23	31.9
Observed price	2023-02-27	32.9
Observed price	2023-03-11	29.8
Observed price	2023-03-23	37.3
Observed price	2023-04-12	28.3
Observed price	2023-04-16	29.7
Observed price	2023-04-28	24.8
Observed price	2023-05-10	28.1
Observed price	2023-05-30	33.0
Observed price	2023-06-11	42.5
Observed price	2023-06-19	39.7
Observed price	2023-07-09	39.4
Observed price	2023-07-17	50.2
Observed price	2023-08-02	51.3
Observed price	2023-08-10	46.7
Observed price	2023-08-18	40.1
Observed price	2023-09-03	51.3
Observed price	2023-09-07	49.9
Observed price	2023-09-23	43.5
Observed price	2023-10-01	44.4
Observed price	2023-10-21	31.5
Observed price	2023-10-25	31.1
Observed price	2023-11-06	23.1
Observed price	2023-11-18	25.7
Observed price	2023-11-30	23.5
Observed price	2023-12-24	28.9
Observed price	2024-01-01	25.5
Observed price	2024-01-05	22.4
Observed price	2024-01-25	16.35
Observed price	2024-02-06	15.04
Observed price	2024-02-14	18.78
Observed price	2024-03-05	16.74
Observed price	2024-03-13	15.09
Observed price	2024-03-21	14.82
Observed price	2024-04-06	11.57
Observed price	2024-04-22	10.59
Observed price	2024-04-30	11.98
Observed price	2024-05-04	11.71
Observed price	2024-05-08	11.25
Observed price	2024-05-28	11.17
Observed price	2024-06-13	13.53
Observed price	2024-06-25	10.48
Observed price	2024-07-11	15.57
Observed price	2024-07-19	18.77
Observed price	2024-08-04	15.39
Observed price	2024-08-08	13.16
Observed price	2024-08-28	14.84
Observed price	2024-09-01	14.09
Observed price	2024-09-17	12.47
Observed price	2024-09-25	12.02
Observed price	2024-10-11	16.02
Observed price	2024-10-27	16.45
Observed price	2024-11-04	11.71
Observed price	2024-11-16	11.25
Observed price	2024-12-02	12.14
Observed price	2024-12-06	11.47
Observed price	2024-12-26	16.29
Observed price	2024-12-30	16.98
Observed price	2025-01-19	12.51
Observed price	2025-01-23	12.50
Observed price	2025-02-12	10.39
Observed price	2025-02-20	12.10
Observed price	2025-03-08	8.49
Observed price	2025-03-16	9.35
Observed price	2025-04-01	7.85
Observed price	2025-04-05	7.04
Observed price	2025-04-09	8.76
Observed price	2025-05-07	8.31
Observed price	2025-05-15	9.34
Observed price	2025-05-23	9.04
Observed price	2025-06-12	11.92
Observed price	2025-06-20	11.41
Observed price	2025-07-06	15.34
Observed price	2025-07-14	13.86
Observed price	2025-07-26	21.1
Observed price	2025-08-11	17.48
Observed price	2025-08-23	21.1
Observed price	2025-08-27	24.3
Observed price	2025-09-16	28.6
Observed price	2025-09-24	32.3
Observed price	2025-10-10	25.2
Observed price	2025-10-14	27.4
Observed price	2025-10-18	25.1
Observed price	2025-11-07	23.9
Observed price	2025-11-19	19.57
Observed price	2025-12-05	24.7
Observed price	2025-12-17	21.5
Observed price	2025-12-29	20.6
Observed price	2026-01-14	26.0
Observed price	2026-01-18	29.0
Observed price	2026-02-03	24.9
Observed price	2026-02-11	27.4
Observed price	2026-03-03	41.6
Observed price	2026-03-11	42.5
Observed price	2026-03-27	32.5
Observed price	2026-03-31	37.1
Observed price	2026-04-20	91.3
Observed price	2026-04-28	85.1
Observed price	2026-05-14	101
Observed price	2026-05-18	85.7
Observed price	2026-06-03	115
Observed price	2026-06-15	116
Observed price	2026-07-01	84.4
Observed price	2026-07-13	68.0
Observed price	2026-07-21	98.9
Observed price	2026-07-29	65.4
Observed price	2026-08-14	134
Observed price	2026-08-22	100.0
Observed price	2026-09-03	76.3
Observed price	2026-09-15	81.6
Observed price	2026-09-25	104
Published advisor forecast	2026-09-18	93.5
Published advisor forecast	2026-12-18	84.1
Published advisor forecast	2027-03-18	95.9
Published advisor forecast	2027-06-18	102
Published advisor forecast	2027-09-18	93.5
Published advisor forecast	2027-12-18	87.9
Published advisor forecast	2028-03-18	96.7
Published advisor forecast	2028-06-18	102
Published advisor forecast	2028-09-18	108
Published advisor forecast	2028-12-18	98.0
Published advisor forecast	2029-03-18	105
Published advisor forecast	2029-06-18	109
Published advisor forecast	2029-09-18	104
Published advisor forecast	2029-12-18	112
Published advisor forecast	2030-03-18	115
Published advisor forecast	2030-06-18	107
Published advisor forecast	2030-09-18	114
Published advisor forecast	2030-12-18	118
Published advisor forecast	2031-03-18	120
Published advisor forecast	2031-06-18	116
Published advisor forecast	2031-09-18	123

2. Scenarios & Signals

Bull case

The bull case activates if snaps back above 45% while bookings keep compounding — margin recovery and order growth must arrive together, not sequentially. Then $150M of fiscal 2027 revenue drops far more to operating income than modelled, the installed base doubles WaferPak consumable revenue, and a memory or co-packaged-optics qualification extends the addressable market. Operating leverage plus a widened moat justifies a premium multiple on genuinely larger earnings, and the shares compound well past $180.

Bear case

The bear case activates when one lead customer defers and stays in the thirties simultaneously. Revenue misses the $130M floor, the operating-leverage story collapses into a second consecutive loss year, and the at-the-market programme is tapped again from a lower price — diluting holders precisely when the narrative premium evaporates. With a 5% risk-free rate anchoring discount rates, a 56x sales multiple has nowhere to rest. The shares could halve without any change in long-term technology logic.

Current crowd narrative

The settled belief is that Aehr has become the toll booth on AI burn-in, and that $100.6M of effective plus 160-200% guided growth are already banked revenue. A 327% year-to-date run, Jefferies at $175 and a September Oppenheimer initiation reinforce it [1][12][15]. The anchor is the booking number; almost nobody anchors on falling to 35.3%.

Alpha-gap assessment

The crowd overestimates what these shares are worth: the inflection is real but fully paid for. The overlooked evidence is arithmetic, not narrative — fourteen points of gross-margin erosion since fiscal 2024 alongside roughly $100M of at-the-market issuance means a tripled top line reaches materially fewer dollars per share than a 56x sales multiple assumes [6][7]. Sustaining $93.50 requires near-flawless execution to roughly $400M of revenue at semiconductor-leader margins by fiscal 2031. That is a forecast, not a floor.

Convergence catalyst

The first-quarter fiscal 2027 print, estimated between October 5 and 12, 2026, is the recognition event [14]. It is the first disclosure where backlog conversion and appear together on one page. The first observable sign of repricing will be the margin line, not the revenue headline.

Paywalled preview begins: Macro-regime alignment

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Sentiment and regime

Greed and fear sentiment: 0.6
Expected volatility regime: high_erratic
Convergence-cycle position: overshoot

Primary drivers

Primary drivers supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
ONLY Vendor Holding BOTH BURN IN Modalit	Aehr is the sole supplier pairing wafer-level burn-in with Incal-derived ultra-high-power packaged-part systems, and the order book proves customers pay for that breadth: a record $41M hyperscaler ASIC order and a $22M follow-on from the lead AI processor customer lifted effective backlog to $100.6M at fiscal year-end [3][8]. That breadth underwrites fiscal 2027 guidance of $130-150M and persists until incumbents field an equivalent dual stack.	Not available	+42.0%
Expensive AI Packages MAKE Screening COM	As accelerator packages stack HBM, interface logic and compute onto one substrate, the cost of discovering an infant-mortality die after assembly rises superlinearly, which turns pre-singulation screening from optional into economically compulsory [8]. That arithmetic, not marketing, explains why a networking customer moved from first engagement to volume production within seven months [9]. Demand persists while advanced-package value per unit keeps climbing through the decade.	Not available	+35.0%
Waferpak Consumables ARE THE REAL Annuit	The tester chassis is the razor; the device-specific WaferPak contactor and DiePak carrier are the blades. Designing reliable high-current contactors demands years of empirical materials-science data, which is the genuinely defensible asset rather than the system frame [22]. As the installed base expands with fiscal 2027 shipments, attached consumable revenue should improve mix quality, smooth the lumpy system cycle and raise the floor under gross margin.	Not available	+22.0%
Capital Light Scaling ON A Fortress BALA	Capital expenditure was only $2.1M in fiscal 2026 against a revenue base management expects to roughly triple, so incremental volume consumes working capital rather than plant [6]. Cash, equivalents and restricted cash of $116.5M at May 29, 2026 removes financing risk while the ten-year Treasury sits near 5% [6]. Growth therefore reaches shareholders through operating leverage instead of interest expense or distress financing.	Not available	+15.0%

Primary frictions

Primary frictions supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
A FIVE Percent Discount RATE Meets 56x S	At $93.50 the equity capitalises 56x trailing sales and roughly 20x the top of fiscal 2027 guidance, on a business that consumed $3.3M of operating cash last year [4]. With the Fed at 3.75%-4.00% and the ten-year Treasury at 4.998% on September 18, long-duration cash flows are discounted harder every quarter. Multiple compression, not order failure, is the single likeliest source of drag.	Not available	-38.0%
Gross Margin Bleeding Through THE AI PIV	Gross margin fell from 49.1% in fiscal 2024 to 40.6%, then 35.3% in fiscal 2026 — fourteen points of erosion precisely as the AI mix arrived. If large-system and packaged-part revenue structurally carries lower margin, tripling revenue toward $140M delivers far less earnings per share than the revenue multiple assumes. This is the decisive undisclosed variable; only sustained recovery above 45% validates the operating-leverage case.	Not available	-24.0%
Three Customers Carry THE Entire Backlog	The lead AI processor, lead hyperscale and lead silicon-photonics accounts carry nearly all bookings, and shipments install at a Taiwanese manufacturing partner inside an active tariff and export-control regime [8]. A single qualification loss or deferred capacity decision removes a quarter of forecast revenue. Fiscal 2026 already demonstrated the pattern: bookings converted into revenue with both a lag and a haircut.	Not available	-20.0%
Dilution Bought THE Fortress	Roughly $100M was raised through the at-the-market programme during fiscal 2026, which explains equity rising from $123M to $220M while the company reported a $7.1M loss [6][7]. Shareholders purchased that balance sheet; operations did not earn it. Founder Posedel sold about $1.77M of stock and insiders were net sellers over the trailing year [7]. Management treats an elevated price as funding currency, so further issuance is likely.	Not available	-14.0%

Tail opportunities

Tail opportunities supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Memory Makers Adopt Wafer Level BURN IN	The step-change trigger would be a major HBM or DRAM supplier qualifying wafer-level burn-in for production screening, plausibly disclosed during fiscal 2028 or 2029 as stacked-memory yield losses become intolerable at accelerator package prices. Memory volumes dwarf logic accelerators, so a single qualification would convert a roughly $0.9 billion burn-in platform market into a multi-billion one [22] and re-rate Aehr from lumpy equipment vendor to installed-base compounder. It stays below fifty percent because memory makers historically favour known-good-die alternatives and incumbent suppliers.	30.0%	+85.0%
AN Incumbent BUYS THE Chokepoint	Advantest, Teradyne or FormFactor could acquire Aehr outright to own the contactor intellectual property rather than replicate years of high-current materials-science data [20][22]. The likely window is fiscal 2028-2030, once a proven revenue run-rate above $200M makes the asset digestible and the strategic gap in burn-in obvious. A control premium on a scarce chokepoint asset would be paid on strategic, not cash-flow, logic. Probability stays modest because the current valuation already embeds much of a takeover premium and antitrust scrutiny of semiconductor-equipment consolidation has tightened.	18.0%	+45.0%

Tail risks

Tail risks supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Incumbents Field AN Integrated TEST CELL	Advantest and FormFactor have already collaborated on an automated wafer-level test cell for silicon photonics combining the V93000 with FormFactor probers [21]. If that architecture is extended to high-power burn-in and qualified at Aehr's lead AI processor account during fiscal 2028-2030, the sole-vendor argument that justifies the current multiple dissolves. Global service footprints favour incumbents on large test floors [20]. Probability stays below half because contactor reliability data takes years to accumulate and switching costs inside qualified production flows are genuinely high.	28.0%	-50.0%
AI Capex Digestion AIR Pocket	The most probable bear trigger is a hyperscaler capacity-digestion pause in late 2028 or 2029, after two years of accelerator buildout. Aehr's revenue is not subscription-like; it is a handful of purchase orders, so a six-month deferral by one lead customer would collapse quarterly revenue and reverse the operating leverage narrative immediately. With no margin of safety at twenty times forward sales, the de-rating would be violent. It remains below fifty percent because AI inference demand and package complexity keep rising even when capex growth slows.	40.0%	-45.0%

Step-by-step forecast path

Universal Investor forecast path for prediction task predrqst_batch_task__xrefsubjtskconf_70a40b28-2fba-5fc4-a918-b8d67b09a466__sb7__20260920064920277661
Step	Forecast date	Step change	Projected value (USD)	Scenario rationale
1	December 18, 2026	-10.0%	84.14	The first-quarter fiscal 2027 print between October 5 and 12 tests backlog conversion. Revenue accelerates but gross margin near the mid-thirties disappoints euphoric positioning while the ten-year near 5% compresses a 56x sales multiple.
2	March 18, 2027	+14.0%	95.92	Shipments of the $22M AI processor order land at the Taiwanese manufacturing partner, revenue roughly doubles year over year, and January guidance reaffirms the $130-150M range. Momentum capital returns after the autumn reset.
3	June 18, 2027	+6.0%	101.68	Silicon-photonics and optical-interconnect follow-on shipments sustain sequential growth, but heavier system mix keeps gross margin below forty percent. Gains track delivered earnings rather than any further multiple expansion in a restrictive rate regime.
4	September 18, 2027	-8.0%	93.54	Fiscal 2027 results confirm roughly $140M of revenue and the first profitable year, yet the initial fiscal 2028 guide implies deceleration from a drawn-down backlog. Expectations reset lower despite the operational win.
5	December 18, 2027	-6.0%	87.93	Accelerator customers digest 2027 capacity additions, bookings turn lumpy and one hyperscaler defers a qualification slot. Persistent policy restriction keeps discount rates elevated, so a still-expensive multiple contracts further into year-end.
6	March 18, 2028	+10.0%	96.72	New packaged-part burn-in wins for custom ASICs restore bookings growth while WaferPak consumable revenue rises with a tripled installed base. Improving mix lifts gross margin and rebuilds confidence in operating leverage.
7	June 18, 2028	+5.0%	101.56	Steady conversion of a rebuilt backlog delivers mid-teens revenue growth, and the expanded Fremont capacity absorbs volume without capital intensity. Solid execution supports the price without triggering any valuation step-change.
8	September 18, 2028	+6.0%	107.65	Fiscal 2028 results show gross margin recovering toward the low forties as consumables mix improves. The market rewards visible proof that revenue scale finally converts into durable earnings per share.
9	December 18, 2028	-9.0%	97.96	A semiconductor equipment down-leg arrives as hyperscaler capex growth normalises. Extreme customer concentration amplifies the drawdown when a single deferred production order removes roughly a quarter of consensus revenue.
10	March 18, 2029	+7.0%	104.82	Order recovery led by high-bandwidth memory evaluation and co-packaged optics screening. Management reinstates guidance after the air pocket, and the shares recover part of the cyclical discount applied three months earlier.
11	June 18, 2029	+4.0%	109.01	Installed-base consumable revenue now cushions system lumpiness, producing steadier quarterly results. Modest appreciation reflects compounding earnings against a multiple still deflating from its 2026 speculative peak toward sector norms.
12	September 18, 2029	-5.0%	103.56	Fiscal 2029 results reveal pricing pressure as incumbent test vendors bundle burn-in into integrated cells. Gross margin guidance trims, and investors mark down the sole-vendor premium embedded since 2026.
13	December 18, 2029	+8.0%	111.85	A large qualification win in packaged-part burn-in for next-generation accelerators restores the growth narrative. Easier monetary conditions by this point lift the discount rate constraint on long-duration semiconductor equipment valuations.
14	March 18, 2030	+3.0%	115.20	Revenue growth settles into the twenties percent range with stable low-forties gross margin. The equity behaves like a maturing semiconductor capital-equipment name rather than a speculative AI derivative.
15	June 18, 2030	-7.0%	107.14	Competitive test-cell launches from an established vendor pressure win rates at a second-tier account. Guidance held flat sequentially, and the market discounts the durability of Aehr's contactor-based advantage.
16	September 18, 2030	+6.0%	113.57	Fiscal 2030 results show consumables approaching a third of revenue, structurally improving mix and cash conversion. Investors reward recurring economics that reduce the historic feast-and-famine quarterly pattern.
17	December 18, 2030	+4.0%	118.11	Advanced packaging complexity keeps screening demand growing, and free cash flow turns consistently positive without further equity issuance. Steady compounding replaces narrative as the driver of the share price.
18	March 18, 2031	+2.0%	120.47	A mature, profitable equipment franchise trades on earnings rather than stories. Incremental appreciation tracks modest guidance raises, with the share count now stable after the at-the-market programme lapses unused.
19	June 18, 2031	-4.0%	115.65	A mid-cycle inventory correction across semiconductor test equipment trims bookings for two quarters. Concentration again amplifies the move, though a net-cash balance sheet limits the depth of the drawdown.
20	September 18, 2031	+6.0%	122.59	Fiscal 2031 closes with revenue near $400M and high-twenties operating margin, validating the long thesis on fundamentals. Persistent strategic-acquisition speculation adds a modest premium to the closing quarter.

Advisor and configuration

Advisor: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release
Persona: Universal Investor
Archetype: The Polymath
Model: 2026-07-24 release
Provider: Anthropic
Mode: RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity
Task configuration: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release__equity__json__extnd_invest_thesis_4q_alphassym__ts_num_desc__h5y_s3m__var1__researcher__standard_creativity_high_thinking__batch
Forecast horizon: 5 year
Forecast steps: 20 steps of 3 month
Assembly type: Balanced Assembly
Assembly name: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release RESEARCHER Forecast Assembly
Input format: inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
Output format: Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

Read the complete Universal Investor advisor methodology

Configuration components

aiassmprmtcmpnt_b995bbe2-6a15-55be-a576-525904f696e8
aiassmprmtcmpnt_c55d1851-d218-5d30-b83b-54bbda31e2ee
aiassmprmtcmpnt_930157b1-05d7-5699-bf0a-738645ee42fd
aiassmprmtcmpnt_3c0c459a-0d4a-50ca-87df-c172ec5618aa
aiassmprmtcmpnt_8115cc2a-d418-54b1-a616-49dfa91195f4

Research sources

[1]AEHR Stock Quote Price and Forecast | CNNcnn.com
[2]Investor Relations | Aehr Test Systemsaehr.com
[3]Aehr Test Systems Reports Fiscal 2026 Fourth Quarter and Full Year Financial Results with Record Quarterly Bookings and $100 Million Effective Backlog - Aehr Test Systemsaehr.com
[4]Aehr Test Systems Reports Fiscal 2026 Fourth Quarter and Full Year Financial Results with Record Quarterly Bookings and $100 Million Effective Backlogfinance.yahoo.com
[5]aehr_ex991.htmsec.gov
[6]Earnings call transcript: Aehr Test Systems tops Q4 2026 forecasts, stock jumps 29% By Investing.cominvesting.com
[7]Aehr Test Systems (NasdaqCM:AEHR) - Earnings & Revenue Performance - Simply Wall Stsimplywall.st
[8]Aehr Receives $22 Million Follow-On Order for AI Processor Wafer-Level Burn-In Systems - Aehr Test Systemsaehr.com
[9]Aehr Receives Follow-On Order from Major Silicon Photonics Customer for Fully Automated Wafer-Level Burn-In System for Hyperscale Data Center Optical Interconnect - Aehr Test Systemsaehr.com
[10]Aehr Receives Follow-On Order for Fully Automated Wafer-Level Burn-In Systems Powering AI Optical I/O and Data Center Interconnects - Aehr Test Systemsaehr.com
[11]Semiconductor Test and Burn-in | Aehr Test Systemsaehr.com
[12]Aehr Test Systems (AEHR) Stock Price & Overviewstockanalysis.com
[13]Aehr Test Systems - 15 Year Stock Price History | AEHR | MacroTrendsmacrotrends.net
[14]AEHR Earnings Dates, Upcoming and Historical Aehr Test Systemsmarketchameleon.com
[15]Aehr Test Systems, Inc. (AEHR) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com
[16]Aehr Test Systems receives order for wafer-level burn-in system By Investing.cominvesting.com
[17]AEHR TEST SYSTEMS - Form 8-K - FY2026sec.gov
[18]Aehr Test Systems Reports Fiscal 2026 First Quarter Financial Results; Strong AI and Data Center-Related Semiconductor Test and Burn-in Activity Underscores Multi-Year Market Opportunity - Aehr Test Systemsaehr.com
[19]The GPU Tsunami: Testing, Testing… - by Ben Bajarinthediligencestack.com
[20]PW Consulting: Wafer Level Burn-In Market Poised to Reach USD 3,456.2M by 2032, CAGR 13.55%prsync.com
[21]Wafer-Level Burn-In & Reliability Testing Market | Size, Overview, Trends, and Forecast | 2026 – 2030virtuemarketresearch.com
[22]Explore the Global Burn-In and System-Level Test (SLT) Platforms for AI Accelerators Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.futuremarketinsights.com
[23]AEHR Gears Up to Report Q4 Earnings: What's in Store for the Stock?finance.yahoo.com

Back to advisor navigation

End of the paywalled preview

The excerpt from Macro-regime alignment to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Other AI Advisor reports — limited previews

Superintelligence — RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity

Gemini 3.8 Flash

Limited structural preview, provided as simplified HTML. The complete report contains substantially more research: its investment thesis; bull and bear scenarios; macro-regime analysis; drivers, risks and opportunities; quarterly forecast tables and rationale; references and published configuration. Those findings and datasets are not included here. Sign in with the required subscription to open this advisor's full report.